The paper examines 5189 Indian publications on breast cancer research, as covered in Scopus database during [2005][2006][2007][2008][2009][2010][2011][2012][2013][2014] 
INTRODUCTION
Breast cancer is an uncontrolled growth of breast cells. Cancer occurs as a result of mutations, or abnormal changes, in the genes responsible for regulating the growth of cells and keeping them healthy. The genes are in each cell's nucleus, which acts as the "control room" of each cell. Normally, the cells in our bodies replace themselves through an orderly process of cell growth: Healthy new cells take over as old ones die out. However over time, mutations can "turn on" certain genes and "turn off " others in a cell. That changed cell gains the ability to keep dividing without control or order, producing more cells just like it and forming a tumor. A tumor can be benign (not considered cancerous) or malignant (has the potential to be dangerous and if left unchecked, its cells eventually can spread beyond the original tumor to other parts of the body). The term "breast cancer" refers to a malignant tumor that has developed from cells in the breast. [1] Literature review Glynn et al . [7] made a bibliometric assessment the quantity and quality of world breast cancer literature (180,216 papers and 4,136,224 citations), contributed by 155 countries and published in more than 4000 journals. It also identified the key nations and journals involved in its production over the past half-century. Glynn et al. [8] investigated the relationship between malignancy and research, in order to better quantify the degree to which breast cancer is being over-or under-represented in the research world. It examined research output over a 1 year period for the 26 most commonly diagnosed cancers in the UK and elucidate changes in research output over time and then to correlate these changes with improvements in survival.
Shahkhodabandeh et al. [9] analyzed the trend of scientific output (114 articles) in the field of breast cancer research in Iran, using MEDLINE through . Epidemiology and related issues was the most popular subject area investigated by Iranian scientists. Molecular based researches were in second and clinical-related issues were in third condition. About 70% of Iranian publications in this field were published in journals with impact factor between 0.396 and 5.684. Breast cancer research and treatment was the high-impact journal that published Iranian publications. The United States and England were the most prolific countries that published Iranian publications in this field.
Perez-Santos, Martin and Anaya-Ruiz [10] quantitatively assess current research trends with regard to breast cancer in Mexico from 2003 to 2012. Articles were analyzed by scientific output and research performances of individuals, institutes, and collaborative countries with Mexico. Data were retrieved from the Web of Science database from 2003 to 2012. A total of 256 articles were retrieved. The institutions with the majority of publications were the National Autonomous University of Mexico (22.3%), the National Institute of Cancerology (21.9%), and Social Security Mexican Institute (20.3%). Clinical observation studies were the dominant investigation type (64%), and the main types of research were metabolics (24.2%) and pathology (21.5%). This article address key evaluation questions and to establish priorities, define future areas of research, and develop breast cancer control strategies in Mexico.
Kotepuri, Wannaiampikul, Chupeerach, C and Duangmano [11] evaluated research publications in the field of diets and breast cancer. The impact of the economic outcome on national academic productivity was also investigated. Data were retrieved using PubMed for English-language publications. The search included all research for which articles included words relating to "diets and breast cancer." Population and national income data were obtained from publicly available databases. Impact factors for journals were obtained from journal citation reports ® (Thomson scientific). There were 2396 publications from 60 countries in 384 journals with an impact factor. Among them, 1652 (68.94%) publications were original articles. The United States had the highest quantity (51% of total) and highest of mean impact factor (8.852) for publication. Sweden had the highest productivity of publication when adjusted for number of population (6 publications per million populations).
Publications from the Asian nation increased from 5.3% in 2006 to
The female breast is made up mainly of lobules (milk-producing glands), ducts (tiny tubes that carry the milk from the lobules to the nipple), and stroma (fatty tissue and connective tissue surrounding the ducts and lobules, blood vessels, and lymphatic vessels). Most breast cancers begin in the cells that line the ducts (ductal cancers). Some begin in the cells that line the lobules (lobular cancers), while a small number start in other tissues. Breast cancer cells can enter lymphatic vessels and begin to grow in lymph nodes. Most lymphatic vessels in the breast connect to lymph nodes under the arm (axillary nodes). Some lymphatic vessels connect to lymph nodes inside the chest (internal mammary nodes) and those either above or below the collarbone (supraclavicular or infraclavicular nodes). If the cancer cells have spread to lymph nodes, there is a higher chance that the cells could have also gotten into the bloodstream and spread (metastasized) to other sites in the body. [2, 3] Breast cancer is always caused by a genetic abnormality (a "mistake" in the genetic material). However, only 5-10% of cancers are due to an abnormality inherited from your mother or father. Instead, 85-90% of breast cancers are due to genetic abnormalities that happen as a result of the aging process and the "wear and tear" of life in general. [1] Breast cancer rates are much higher in developed nations compared to developing ones. There are several reasons for this, with possibly life-expectancy being one of the key factors -breast cancer is more common in elderly women; women in the richest countries live much longer than those in the poorest nations. The different lifestyles and eating habits of females in rich and poor countries are also contributory factors. [4] According to GLOBOCAN (2012) , breast cancer is the second most common and frequent cancer among women in the world, with an estimated 1.67 million new cases (25% of all cancer cases diagnosed in 2012. Of the total new cases, 883,000 cases were from less developed region (China, 187,000 and India, 145,000 cases) and 794,000 cases (USA, 233,000 cases) from more developed regions of the world. The breast cancer standardized incidence rates age standardized rate (ASR) vary across geographical regions, with ASR ranging from 27/100,000 in middle Africa and Eastern Asia to 96/100,000 in Western Europe. With an estimated 522,000 deaths (India, 70,000 cases and China, 48,000 cases) in 2012, breast cancer is the fifth cause of death from cancer overall. It is, however, the most frequent cause of death in women in less developed region (324,000 deaths, 14.3% of the total) and second cause of deaths in more developed region (198,000 deaths, 15.4%) after lung cancer. Mortality rates in terms of ASR between world regions vary and ranges from 6/100,000 in Eastern Asia to 20/100,000 in Western Africa. Here we notice that the mortality rates is less than that of incidence because of the more favorable survival of breast cancer in (high incidence) developed regions. [5] India is experiencing an unprecedented rise in the number of breast cancer cases across all sections of society, as are also in other countries. Presently, India already has one of the worst survivals from breast cancer in the world and has the highest number of women dying from breast cancer in the world. India also ranks number one in the numbers of healthy life years lost (disability adjusted life years) due to breast cancer. [6] Gupta, et al.: Indian breast cancer publications 14.6% in 2012. Diets and breast cancer-associated research output continues to increase annually worldwide including publications from Asian countries. Although the United States produced the most publications, European nations per capita were higher in publication output.
OBJECTIVES
The main objectives of this study are to study the performance of Indian research in breast cancer during [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] 
METHODOLOGY
The study retrieved and downloaded the publication data of the world and of 15 most productive countries in breast cancer from the Scopus database (http://www.scopus.com) for 10 years during 2005-2014. A number of keywords, such as "breast," "lobul*," "duck*" and "cancer or neoplasm or carcinoma" were used in "title, abstract and keyword" tag and restricting it to the period 2005-2014 in "date range tag" was used for searching the global publication data and this become the main search string. When the main search string with restricted to 15 most productive countries in "country tag," as shown below, the publication data on 15 productive countries were obtained. When the main search string is further restricted to "subject area tag," "country tag," "source title tag," "journal title name" and "affiliation tag," we got information on distribution of publications by subject, collaborating countries and organization-wise, etc. For citation data, the 3 years, 2 years, 1 year citation window was used for publications during 2005-2012, 2013 and 2014. In addition, citations to publications was also collected from date of publication till the end of February 2015 for sections 4.1 and 4.10.
(((TITLE-ABS-KEY (breast) and TITLE-ABS-KEY (cancer or neoplasm or carcinoma)) and PUBYEAR >2004 and PUBYEAR <2015) or ((TITLE-ABS-KEY(breast and lobul*) and TITLE-ABS-KEY (cancer or neoplasm or carcinoma)) and PUBYEAR >2004 and PUBYEAR <2015) or ((TITLE-ABS-KEY (breast and duct*) and TITLE-ABS-KEY (cancer or neoplasm or carcinoma)) and PUBYEAR >2004 and PUBYEAR <2015)) (((TITLE-ABS-KEY (breast) and TITLE-ABS-KEY (cancer or neoplasm or carcinoma)) and PUBYEAR >2004 and PUBYEAR <2015) or ((TITLE-ABS-KEY (breast and lobul*) and TITLE-ABS-KEY (cancer or neoplasm or carcinoma)) and PUBYEAR >2004 and PUBYEAR <2015) or ((TITLE-ABS-KEY (breast and duct*) and TITLE-ABS-KEY (cancer or neoplasm or carcinoma)) and PUBYEAR >2004 and PUBYEAR <2015)) and (LIMIT-TO (AFFILCOUNTRY, "India"))
ANALYSIS
The 
Global publication share and citation impact of top 15 most productive countries
The global research output in breast cancer originated in more than 100 countries during 2004-2013. Table 6 ]. 
International collaboration

Distribution of publications by treatment methods
Distribution of research output by geographical areas
Profile of top 15 most productive organizations
The productivity of 15 most productive Indian organizations in breast cancer varied from 50 to 270 publications and together contributed 27.89% (1447 publications) share in the cumulative publications output of India in breast cancer research during 2005-2014. The scientometric profile of these 15 Indian organizations is presented in Table 8 . 
Medium of communication
The 15 Table 9 ].
High cited papers
There were 33 papers (22 articles, 10 reviews and 1 short survey) in Indian breast cancer research, which have received 100 or more citations from the date of their publication till February 2015. These 33 papers together received 5026 citations, with an average citation per paper of 152.30. Of 33 papers, 27 received citations from 100 to 199, 5 from 200 to 299 and 1 from 300 to 399. Of the 33 high cited papers, 14 papers were zero collaborative (single institution papers), 2 national collaborative and 17 international collaborative (9 bilateral and 8 multinational collaborative). Among the 17 international collaborative publications, USA authors had both first and corresponding authorship in 9 papers, Belgium in two papers, India in two papers (in one paper only corresponding authorship), U.K., Japan and France (only first author) in one paper each. Twenty-seven Indian organizations are involved in these 31 high cited papers, of which the largest number of papers [5] came from Institute of Life Sciences, Bhubaneshwar, followed by TMC, Mumbai, AIIMS, New Delhi, IIT, Madras and Birla Institute of Technology and Science, Pilani (2 papers The authors indicate that cancer prevention is still not a priority in India as the emphasis remains on treatment of cancer and strengthening of tertiary cancer hospitals, rather than prevention via screening or early detection of cancer in India. Therefore, there is a need for educating the population about breast selfawareness and advice to seek medical attention earlier for breast concerns, as well as ensuring healthy lifestyle choices to reduce risk can potentially have a significant impact in managing the problem of breast cancer in India. Furthermore, the government programs on cancer require several organizational, budgetary and human resources, and the accessibility of breast cancer diagnostic, referral, treatment and palliative care facilities should be improved simultaneously.
SUMMARY AND CONCLUSIONS
